Atlas Trials

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

Clinical trial NCT00620269 · UNKNOWN

Trial details

NCT number
NCT00620269
Sponsor
National Cancer Center, Korea
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CancerNSCLC
Start date
2008-02-01
Primary completion
2015-03-01
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.